Publications by authors named "Andreas Hochhaus"

100Publications

Clinical, social, and psycho-oncological needs of adolescents and young adults (AYA) versus older patients following hematopoietic stem cell transplantation.

J Cancer Res Clin Oncol 2020 Oct 14. Epub 2020 Oct 14.

Klinik für Innere Medizin II, Abteilung Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07740, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-020-03419-zDOI Listing
October 2020

CML - Not only BCR-ABL1 matters.

Best Pract Res Clin Haematol 2020 Sep 7;33(3):101194. Epub 2020 Jun 7.

Abteilung Hämatologie/Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Am Klinikum 1, 07747 Jena, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2020.101194DOI Listing
September 2020

Polymethine Dye-Functionalized Nanoparticles for Targeting CML Stem Cells.

Mol Ther Oncolytics 2020 Sep 25;18:372-381. Epub 2020 Jul 25.

Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07747 Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.omto.2020.07.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452122PMC
September 2020

EZH2 in Myeloid Malignancies.

Cells 2020 Jul 8;9(7). Epub 2020 Jul 8.

Klinik für Innere Medizin II, Universitätsklinikum Jena, 07743 Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells9071639DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407223PMC
July 2020

Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensity.

Bone Marrow Transplant 2020 Jun 30. Epub 2020 Jun 30.

Klinik für Innere Medizin II, Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-020-0984-4DOI Listing
June 2020

Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation.

Ann Hematol 2020 Jun 23. Epub 2020 Jun 23.

Abteilung Hämatologie und Internistische Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-04152-wDOI Listing
June 2020

Clara Bloomfield MD: Queen of AML. Dare to cross her at your risk (May 15, 1942 to March 1, 2020).

Bone Marrow Transplant 2020 Jul 8;55(7):1516-1518. Epub 2020 Apr 8.

Department of Hematology & Oncology, University Hospital Jena, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-020-0881-xDOI Listing
July 2020

SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders.

Leukemia 2020 08 25;34(8):2206-2216. Epub 2020 Mar 25.

Klinik für Innere Medizin II, Abteilung Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-0803-3DOI Listing
August 2020

A 19-year-old patient with atypical chronic myeloid leukemia.

Ann Hematol 2020 May 19;99(5):1145-1148. Epub 2020 Mar 19.

Abteilung Hämatologie und Internistische Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Am Klinikum 1, 07740, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-03992-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196939PMC
May 2020

Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry.

J Cancer Res Clin Oncol 2020 Apr 20;146(4):1065-1077. Epub 2020 Feb 20.

Klinik für Innere Medizin II, Hämatologie, Onkologie, Immunologie, Infektiologie und Palliativmedizin, Schwarzwald-Baar Klinikum, Klinikstr. 11, 78052, Villingen-Schwenningen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-020-03139-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085479PMC
April 2020

Phosphorylation-Dependent Differences in CXCR4-LASP1-AKT1 Interaction between Breast Cancer and Chronic Myeloid Leukemia.

Cells 2020 02 14;9(2). Epub 2020 Feb 14.

Klinik für Innere Medizin II, Abteilung für Hämatologie und internistische Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07747 Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells9020444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072741PMC
February 2020

Knockout of LASP1 in CXCR4 expressing CML cells promotes cell persistence, proliferation and TKI resistance.

J Cell Mol Med 2020 Mar 19;24(5):2942-2955. Epub 2020 Jan 19.

Abteilung für Hämatologie und internistische Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcmm.14910DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077607PMC
March 2020

Measuring Phagocytosis of Aspergillus fumigatus Conidia by Human Leukocytes using Flow Cytometry.

J Vis Exp 2019 12 7(154). Epub 2019 Dec 7.

Infections in Hematology and Oncology, Leibniz Institute for Infection Biology and Natural Product Research; Department for Hematology and Medical Oncology, Jena University Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/60397DOI Listing
December 2019

Do persons with chronic myeloid leukaemia have normal or near normal survival?

Leukemia 2020 02 20;34(2):333-335. Epub 2019 Dec 20.

Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0699-yDOI Listing
February 2020

Molecular-defined clonal evolution in patients with chronic myeloid leukemia who were exposed to ionizing radiation following the Chernobyl nuclear disaster.

Leukemia 2020 02 13;34(2):645-650. Epub 2019 Dec 13.

Department of Hematology and Transplantology, National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0679-2DOI Listing
February 2020

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.

N Engl J Med 2019 12;381(24):2315-2326

From the South Australian Health and Medical Research Institute and the University of Adelaide, Adelaide, SA, Australia (T.P.H., D.Y., D.M.R.); Memorial Sloan Kettering Cancer Center, New York (M.J.M., M.S.T., J.H.P.); University of Texas M.D. Anderson Cancer Center, Houston (J.E.C.); Kobe University Graduate School of Medicine, Kobe (H.M.), and the National Cancer Center Hospital East, Chiba (Y.M.) - both in Japan; Hôpital Saint-Louis, Paris (D.R.), and the University of Bordeaux, Bordeaux (F.-X.M.) - both in France; Dana-Farber Cancer Institute, Boston (D.J.D.); Sapienza University, Rome (M.B.); Singapore General Hospital, Singapore (Y.-T.G.); University of Michigan Comprehensive Cancer Center, Ann Arbor (M.T.); Universitätsklinikum Jena, Jena (A.H.), Charité Hospital, Berlin (P.C.), and the Department for Hematology-Oncology, Goethe University Hospital, Frankfurt am Main (F.L.) - all in Germany; University of Cardiff, Cardiff, United Kingdom (O.O.); Veterans Affairs Portland Health Care System (M.C.H.) and Oregon Health and Science University Knight Cancer Institute (M.C.H., B.J.D.), Portland; Hospital de la Princesa and Instituto de Investigación Sanitaria Princesa, Madrid (J.L.S.); Huntsman Cancer Institute, University of Utah, Salt Lake City (M.W.N.D.); Amsterdam University Medical Centers, VU University Medical Center, Amsterdam (J.J.W.M.J.); Novartis Pharma, Basel, Switzerland (D.H., Y.D., C.M., F.H.-P., K.G.V.); and Seoul St. Mary's Hematology Hospital, Catholic University of Korea, Seoul, South Korea (D.-W.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1902328DOI Listing
December 2019

Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia.

J Mol Diagn 2020 01 24;22(1):81-89. Epub 2019 Oct 24.

Medical Faculty, University of Leipzig, Leipzig, Germany; Division for Hematology and Medical Oncology, Asklepios Klinikum Weißenfels, Weißenfels, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2019.08.007DOI Listing
January 2020

Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells.

J Cancer Res Clin Oncol 2019 Nov 17;145(11):2675-2687. Epub 2019 Sep 17.

Klinik Innere Medizin II, Abteilung Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-019-03026-7DOI Listing
November 2019

Open-Label Phase II Evaluation of Imatinib in Primary Inoperable or Incompletely Resected and Recurrent Glioblastoma.

Oncology 2020 12;98(1):16-22. Epub 2019 Sep 12.

Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000502483DOI Listing
January 2020

5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes.

J Cancer Res Clin Oncol 2019 Nov 10;145(11):2835-2843. Epub 2019 Sep 10.

Abteilung Hämatologie und Internistische Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-019-03016-9DOI Listing
November 2019

A Mosquito Bite with Devastating Complications in an Immunocompromised Patient.

Case Rep Oncol 2019 Jan-Apr;12(1):22-28. Epub 2019 Jan 4.

Klinik für Innere Medizin II, Hämatologie und internistische Onkologie, Universitätsklinikum Jena, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000495878DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381905PMC
January 2019

Importance of and Satisfaction with Information about Their Disease in Cancer Patients.

J Cancer Educ 2020 04;35(2):403-411

Klinik für Innere Medizin II, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13187-019-1480-7DOI Listing
April 2020

The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey.

Ann Hematol 2019 Mar 24;98(3):713-722. Epub 2019 Jan 24.

Klinik für Innere Medizin II, Abt. Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03621-1DOI Listing
March 2019

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.

Haematologica 2019 05 4;104(5):955-962. Epub 2018 Dec 4.

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.206797DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518910PMC
May 2019

Information needs and usage of complementary and alternative medicine in members of a German self-help group for gastrointestinal stroma tumours, sarcoma, and renal cancer.

Complement Ther Med 2018 Dec 11;41:105-110. Epub 2018 Sep 11.

Klinik für Innere Medizin II, Universitätsklinikum Jena, Am Klinikum 1, 07747 Jena, Germany. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09652299183063
Publisher Site
http://dx.doi.org/10.1016/j.ctim.2018.09.008DOI Listing
December 2018

[Chronic Myelogenous Leukemia].

Dtsch Med Wochenschr 2018 09 10;143(18):1304-1310. Epub 2018 Sep 10.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-121023DOI Listing
September 2018

Dasatinib.

Recent Results Cancer Res 2018;212:29-68

Abteilung Hämatologie/Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Erlanger Allee 101, 07740, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-91439-8_2DOI Listing
May 2019

Human MAIT cells are rapidly activated by Aspergillus spp. in an APC-dependent manner.

Eur J Immunol 2018 10 13;48(10):1698-1706. Epub 2018 Aug 13.

Klinik für Innere Medizin II, Hematology and Oncology, Jena University Hospital, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201747312DOI Listing
October 2018

Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia.

Leukemia 2018 09 13;32(9):2046-2049. Epub 2018 Jun 13.

Sektion für Hämatologie, Onkologie und Stammzelltransplantation, Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Jena, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0157-2DOI Listing
September 2018

Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

Authors:
Nimitha R Mathew Francis Baumgartner Lukas Braun David O'Sullivan Simone Thomas Miguel Waterhouse Tony A Müller Kathrin Hanke Sanaz Taromi Petya Apostolova Anna L Illert Wolfgang Melchinger Sandra Duquesne Annette Schmitt-Graeff Lena Osswald Kai-Li Yan Arnim Weber Sonia Tugues Sabine Spath Dietmar Pfeifer Marie Follo Rainer Claus Michael Lübbert Christoph Rummelt Hartmut Bertz Ralph Wäsch Johanna Haag Andrea Schmidts Michael Schultheiss Dominik Bettinger Robert Thimme Evelyn Ullrich Yakup Tanriver Giang Lam Vuong Renate Arnold Philipp Hemmati Dominik Wolf Markus Ditschkowski Cordula Jilg Konrad Wilhelm Christian Leiber Sabine Gerull Jörg Halter Claudia Lengerke Thomas Pabst Thomas Schroeder Guido Kobbe Wolf Rösler Soroush Doostkam Stephan Meckel Kathleen Stabla Stephan K Metzelder Sebastian Halbach Tilman Brummer Zehan Hu Joern Dengjel Björn Hackanson Christoph Schmid Udo Holtick Christof Scheid Alexandros Spyridonidis Friedrich Stölzel Rainer Ordemann Lutz P Müller Flore Sicre-de-Fontbrune Gabriele Ihorst Jürgen Kuball Jan E Ehlert Daniel Feger Eva-Maria Wagner Jean-Yves Cahn Jacqueline Schnell Florian Kuchenbauer Donald Bunjes Ronjon Chakraverty Simon Richardson Saar Gill Nicolaus Kröger Francis Ayuk Luca Vago Fabio Ciceri Antonia M Müller Takeshi Kondo Takanori Teshima Susan Klaeger Bernhard Kuster Dennis Dong Hwan Kim Daniel Weisdorf Walter van der Velden Daniela Dörfel Wolfgang Bethge Inken Hilgendorf Andreas Hochhaus Geoffroy Andrieux Melanie Börries Hauke Busch John Magenau Pavan Reddy Myriam Labopin Joseph H Antin Andrea S Henden Geoffrey R Hill Glen A Kennedy Merav Bar Anita Sarma Donal McLornan Ghulam Mufti Betul Oran Katayoun Rezvani Omid Shah Robert S Negrin Arnon Nagler Marco Prinz Andreas Burchert Andreas Neubauer Dietrich Beelen Andreas Mackensen Nikolas von Bubnoff Wolfgang Herr Burkhard Becher Gerard Socié Michael A Caligiuri Eliana Ruggiero Chiara Bonini Georg Häcker Justus Duyster Jürgen Finke Erika Pearce Bruce R Blazar Robert Zeiser

Nat Med 2018 Apr;24(4):526

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm0418-526cDOI Listing
April 2018

B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies.

Cell 2018 04 15;173(2):470-484.e18. Epub 2018 Mar 15.

Department of Systems Biology, Beckman Research Institute, and City of Hope Comprehensive Cancer Center, Monrovia, CA 91016, USA; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94143, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2018.02.048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284818PMC
April 2018

Managing myeloproliferative neoplasms evidence based on the ELN treatment recommendations 2018.

Leukemia 2018 05 27;32(5):1055-1056. Epub 2018 Feb 27.

Klinik für Innere Medizin II, Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0079-zDOI Listing
May 2018

Therapy-free remission in chronic myeloid leukemia: possible mechanism.

Expert Rev Hematol 2018 04 9;11(4):269-272. Epub 2018 Mar 9.

b Abteilung Hämatologie/Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena , Jena , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2018.1442213DOI Listing
April 2018

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

Authors:
Nimitha R Mathew Francis Baumgartner Lukas Braun David O'Sullivan Simone Thomas Miguel Waterhouse Tony A Müller Kathrin Hanke Sanaz Taromi Petya Apostolova Anna L Illert Wolfgang Melchinger Sandra Duquesne Annette Schmitt-Graeff Lena Osswald Kai-Li Yan Arnim Weber Sonia Tugues Sabine Spath Dietmar Pfeifer Marie Follo Rainer Claus Michael Lübbert Christoph Rummelt Hartmut Bertz Ralph Wäsch Johanna Haag Andrea Schmidts Michael Schultheiss Dominik Bettinger Robert Thimme Evelyn Ullrich Yakup Tanriver Giang Lam Vuong Renate Arnold Philipp Hemmati Dominik Wolf Markus Ditschkowski Cordula Jilg Konrad Wilhelm Christian Leiber Sabine Gerull Jörg Halter Claudia Lengerke Thomas Pabst Thomas Schroeder Guido Kobbe Wolf Rösler Soroush Doostkam Stephan Meckel Kathleen Stabla Stephan K Metzelder Sebastian Halbach Tilman Brummer Zehan Hu Joern Dengjel Björn Hackanson Christoph Schmid Udo Holtick Christof Scheid Alexandros Spyridonidis Friedrich Stölzel Rainer Ordemann Lutz P Müller Flore Sicre-de-Fontbrune Gabriele Ihorst Jürgen Kuball Jan E Ehlert Daniel Feger Eva-Maria Wagner Jean-Yves Cahn Jacqueline Schnell Florian Kuchenbauer Donald Bunjes Ronjon Chakraverty Simon Richardson Saar Gill Nicolaus Kröger Francis Ayuk Luca Vago Fabio Ciceri Antonia M Müller Takeshi Kondo Takanori Teshima Susan Klaeger Bernhard Kuster Dennis Dong Hwan Kim Daniel Weisdorf Walter van der Velden Daniela Dörfel Wolfgang Bethge Inken Hilgendorf Andreas Hochhaus Geoffroy Andrieux Melanie Börries Hauke Busch John Magenau Pavan Reddy Myriam Labopin Joseph H Antin Andrea S Henden Geoffrey R Hill Glen A Kennedy Merav Bar Anita Sarma Donal McLornan Ghulam Mufti Betul Oran Katayoun Rezvani Omid Shah Robert S Negrin Arnon Nagler Marco Prinz Andreas Burchert Andreas Neubauer Dietrich Beelen Andreas Mackensen Nikolas von Bubnoff Wolfgang Herr Burkhard Becher Gerard Socié Michael A Caligiuri Eliana Ruggiero Chiara Bonini Georg Häcker Justus Duyster Jürgen Finke Erika Pearce Bruce R Blazar Robert Zeiser

Nat Med 2018 03 12;24(3):282-291. Epub 2018 Feb 12.

Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.4484DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029618PMC
March 2018

The use of complementary and alternative medicine by patients in routine care and the risk of interactions.

J Cancer Res Clin Oncol 2018 Mar 22;144(3):551-557. Epub 2018 Jan 22.

Klinik für Innere Medizin II, Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-018-2587-7DOI Listing
March 2018

Reply to K.R. Hoffman.

J Clin Oncol 2017 02 14;35(5):567-568. Epub 2016 Nov 14.

Jorge E. Cortes, MD Anderson Cancer Center, Houston, TX; and Andreas Hochhaus, Universitätsklinikum Jena, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.2944DOI Listing
February 2017

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.

J Clin Oncol 2018 01 1;36(3):231-237. Epub 2017 Nov 1.

Jorge E. Cortes, University of Texas MD Anderson Cancer Center, Houston, TX; Carlo Gambacorti-Passerini, University of Milano-Bicocca, Monza, Italy; Michael W. Deininger, University of Utah, Salt Lake City, UT; Michael J. Mauro, Memorial Sloan Kettering Cancer Center, New York, NY; Charles Chuah, Singapore General Hospital, Duke-National University of Singapore Medical School, Singapore, Singapore; Dong-Wook Kim, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea; Irina Dyagil, National Research Center for Radiation Medicine, Kiev; Nataliia Glushko, Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, Ukraine; Dragana Milojkovic, Imperial College London at Hammersmith Hospital London; Laurence Reilly and Allison Jeynes-Ellis, Avillion, London, United Kingdom; Philipp le Coutre, Charité-Universitätsmedizin Berlin, Berlin; Andreas Hochhaus, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena; Tim H. Brümmendorf, Universitätsklinikum RWTH Aachen, Aachen, Germany; Valentin Garcia-Gutierrez, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain; Eric Leip, Pfizer, Cambridge, MA; Nathalie Bardy-Bouxin, Pfizer International Operation, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.7162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966023PMC
January 2018

Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies.

J Cancer Res Clin Oncol 2017 Dec 14;143(12):2511-2519. Epub 2017 Sep 14.

Abteilung Hämatologie und Internistische Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-017-2518-zDOI Listing
December 2017

Measurement of piperacillin plasma concentrations in cancer patients with suspected infection.

Infection 2017 Oct 17;45(5):629-636. Epub 2017 May 17.

Klinik für Innere Medizin II, Abteilung Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s15010-017-1026-z
Publisher Site
http://dx.doi.org/10.1007/s15010-017-1026-zDOI Listing
October 2017

Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial.

J Cancer Res Clin Oncol 2017 Aug 19;143(8):1613-1619. Epub 2017 Apr 19.

Klinik für Innere Medizin II, Abteilung Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07740, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-017-2424-4DOI Listing
August 2017

Isoform localization of Dectin-1 regulates the signaling quality of anti-fungal immunity.

Eur J Immunol 2017 05 13;47(5):848-859. Epub 2017 Apr 13.

Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/eji.201646849
Publisher Site
http://dx.doi.org/10.1002/eji.201646849DOI Listing
May 2017

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.

N Engl J Med 2017 03;376(10):917-927

From Abteilung Hämatologie-Onkologie, Universitätsklinikum Jena, Jena, Germany (A.H.); the Department of Medicine, University of Chicago, Chicago (R.A.L.); INSERM Centre d'Investigation Clinique 1402, Centre Hospitalier Universitaire de Poitiers, Poitiers, France (F.G.); Fred Hutchinson Cancer Research Center, Seattle (J.P.R.); Centre for Cancer Biology, SA Pathology, University of South Australia and University of Adelaide (S.B.), and the South Australian Health and Medical Research Institute and University of Adelaide (T.P.H.), Adelaide, SA, Australia; University of Bologna, Bologna, Italy (M.B.); the University of Utah Huntsman Cancer Institute, Salt Lake City (M.W.D.); the Hematology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona (F.C.); Novartis, Basel, Switzerland (S.F., C.-E.O., H.D.M.); M.D. Anderson Cancer Center, Houston (H.K.); the University of Newcastle, Newcastle, United Kingdom (S.G.O.); and Knight Cancer Institute, Oregon Health and Science University and Howard Hughes Medical Institute, Portland (B.J.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1609324DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901965PMC
March 2017

Safety issues and management of toxicities associated with new treatments for multiple myeloma.

Expert Rev Hematol 2017 Mar 27;10(3):193-205. Epub 2017 Jan 27.

a Klinik für Innere Medizin II, Abt. Hämatologie und Internistische Onkologie , Universitätsklinikum Jena , Jena , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1284584DOI Listing
March 2017

Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia.

J Clin Oncol 2017 Jan 7;35(2):175-184. Epub 2016 Nov 7.

Sieghart Sopper, Günther Gastl, Matthias Baldauf, Zlatko Trajanoski, and Dominik Wolf, Medical University Innsbruck; Sieghart Sopper and Dominik Wolf, Tyrolean Cancer Research Institute; Matthias Baldauf, Oncotyrol, Innsbruck; Peter Valent, Medical University of Vienna, Vienna, Austria; Satu Mustjoki and Kimmo Porkka, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; Deborah White and Timothy Hughes, South Australian Health and Medical Research Institute and University of Adelaide School of Medicine, Adelaide, South Australia, Australia; Andreas Burchert, Universitätsklinikum Gießen und Marburg and Philipps Universität Marburg, Marburg; Andreas Hochhaus, Thomas Ernst, and Thomas Schenk, Universitätsklinikum Jena, Jena; Dominik Wolf, University Hospital of Bonn, Bonn, Germany; Bjørn T. Gjertsen, University of Bergen, Bergen, Norway; Frank Giles, Northwestern University, Chicago, IL; and Jeroen J.W.M. Janssen and Gert J. Ossenkoppele, Vrije Universiteit Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.0893DOI Listing
January 2017

Impact of FLT3-ITD diversity on response to induction chemotherapy in patients with acute myeloid leukemia.

Haematologica 2017 04 29;102(4):e129-e131. Epub 2016 Dec 29.

Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.157180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395123PMC
April 2017

Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor-Sensitive and -Resistant Chronic Myeloid Leukemia.

Clin Cancer Res 2017 May 17;23(9):2289-2300. Epub 2016 Nov 17.

Department of Hematology and Oncology with Sections BMT and Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1930DOI Listing
May 2017

Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy.

Haematologica 2017 02 17;102(2):e39-e42. Epub 2016 Nov 17.

Faculty of Medicine Carl Gustav Carus, Institute for Medical Informatics and Biometry, Technische Universität Dresden, Mannheim, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.154138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286951PMC
February 2017

Comparison of two dose levels of cyclophosphamide for successful stem cell mobilization in myeloma patients.

J Cancer Res Clin Oncol 2016 Dec 17;142(12):2603-2610. Epub 2016 Sep 17.

Klinik für Innere Medizin II (Abteilung Hämatologie und Internistische Onkologie), Universitätsklinikum Jena, Am Klinikum 1, 07740, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-016-2270-9DOI Listing
December 2016

Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment.

J Cancer Res Clin Oncol 2017 Feb 24;143(2):337-345. Epub 2016 Oct 24.

Klinik für Innere Medizin II (Abteilung Hämatologie und Internistische Onkologie), Universitätsklinikum Jena, Am Klinikum 1, 07740, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-016-2290-5DOI Listing
February 2017